Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alphatec Holdings (ATEC) EPS (Weighted Average and Diluted) (2012 - 2026)

Alphatec Holdings recorded quarterly EPS (Weighted Average and Diluted) of -$0.22 in Q1 2026, down 46.67% quarter-over-quarter from -$0.15 in Q4 2025, and up 37.14% year-over-year from -$0.16 in Q1 2025.

Alphatec Holdings' EPS (Weighted Average and Diluted) history runs 11 years deep, the most recent figure standing at -$0.22 for Q1 2026.

  • In Q1 2026, EPS (Weighted Average and Diluted) rose 37.14% year-over-year to -$0.22; the TTM figure through Mar 2026 stood at -$0.83 (up 27.83% YoY), while the FY2025 annual figure was -$0.96, up 15.04% from the prior year.
  • EPS (Weighted Average and Diluted) came in at -$0.22 for Q1 2026 at Alphatec Holdings, down from -$0.15 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.15 in Q4 2025 to a low of -$0.43 in Q1 2022.
  • A 5-year average of -$0.31 and a median of -$0.34 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
  • Across the five-year window, EPS (Weighted Average and Diluted) retreated 19.44% in 2023 and surged 37.14% in 2026, its largest moves.
  • Alphatec Holdings' EPS (Weighted Average and Diluted) stood at -$0.32 in 2022, then fell by 12.5% to -$0.36 in 2023, then soared by 36.11% to -$0.23 in 2024, then jumped by 34.78% to -$0.15 in 2025, then tumbled by 46.67% to -$0.22 in 2026.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods registered -$0.22, -$0.15, and -$0.19 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.61
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.89
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.66
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.51
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.85
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.24
10 Alphatec Holdings 1.15 Bn 1.01 Bn 136.48 Mn -0.22

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.22
Dec 31, 2025 -0.15
Sep 30, 2025 -0.19
Jun 30, 2025 -0.27
Mar 31, 2025 -0.35
Dec 31, 2024 -0.23
Sep 30, 2024 -0.28
Jun 30, 2024 -0.29
Mar 31, 2024 -0.34
Dec 31, 2023 -0.36
Sep 30, 2023 -0.35
Jun 30, 2023 -0.43
Mar 31, 2023 -0.40
Dec 31, 2022 -0.32
Sep 30, 2022 -0.35
Jun 30, 2022 -0.36
Mar 31, 2022 -0.43
Dec 31, 2021 -0.40
Sep 30, 2021 -0.43
Jun 30, 2021 -0.39
Dec 31, 2020 -0.40
Dec 31, 2015 -0.10
Sep 30, 2015 -1.61
Jun 30, 2015 -0.04
Mar 31, 2015 -0.05
Dec 31, 2014 -0.03
Sep 30, 2014 -0.04
Jun 30, 2014 -0.03
Mar 31, 2014 -0.07
Dec 31, 2013 -0.62
Sep 30, 2013 -0.15
Dec 31, 2012 -0.06